Breethe Abiomed Recovery Trial
Recruiting
18 years - 99 years
All
Phase
N/A
1 Location
Brief description of study
The intent of the BART Study is to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns identified through study analysis, to serve as a tool to measure and improve the quality of patient care and to serve as a resource for future research and regulatory filing
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: cardiopulmonary bypass
-
Age: 18 years - 99 years
-
Gender: All
Male or Female, Age 18 or older, intended treatment is to receive Abiomed Breethe OXY-1 System™
Updated on
04 Aug 2024.
Study ID: 848365